OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
SPHRY
Starpharma Holdings Ltd.
Sponsored ADR (1 ADS : 10 Ordinary)
0.8899
0.00
0.00%
No Inside Bid / Offer
Delayed (15 Min) Trade Data: 12:00am 09/08/2025
0.00
N/A
0
Market Cap calculated only for this class of securities.
37,217,823
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 09/08/2025 | 14:47:18 | 0.8899 | 0.01 | 600 |
| 09/08/2025 | 13:07:00 | 0.88 | -0.01 | 1,800 |
| 09/08/2025 | 10:06:10 | 0.8902 | -0.00 | 200 |
| 09/08/2025 | 09:34:42 | 0.8905 | 0.04 | 100 |
| 09/04/2025 | 10:21:11 | 0.84695 | 0.09 | 100 |
News
$3.7M R&D Tax Incentive ReceivedOTC Disclosure & News Service | 08/27/2025
2025 Appendix 4G and Corporate Governance StatementOTC Disclosure & News Service | 08/25/2025
FY25 Key Financial Results and Annual ReportOTC Disclosure & News Service | 08/25/2025
Filings and Disclosure
Company Description
Starpharma Holdings Limited (ASX: SPL, US OTC: SPHRY) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Our mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of our unique dendrimer technology.
Videos
This company has not added any videos
Best Market
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The Company’s board of directors includes at least two Independent Directors.
Securities
Other Starpharma Holdings Ltd. Securities
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
50.06
Change
0.12 (0.24%)
Bid
N/A
Ask
N/A
Volume
3289
Time
15:35
© 2025 OTC Markets Group Inc.
Terms of ServiceLinking TermsTrademarksPrivacy StatementCode of ConductRisk WarningSupported Browsers